Weight Management
April 7, 2026
·
read

The Complete Guide to Medical Weight Loss in Singapore: GLP-1 Medications, Costs & Online Treatment

Medically reviewed by Dr. Kevin Chua, Medical Director Last updated: April 2026

No items found.

Medically reviewed by Dr. Kevin Chua, Medical Director Last updated: April 2026

About the reviewer Dr. Kevin Chua — Medical Director, noah™. Dr. Chua oversees clinical governance and ensures all treatment plans meet Singapore medical standards.

Medical weight loss has been transformed by GLP-1 receptor agonists — a class of medications that produce significant, sustained weight loss in clinical trials. Medications like semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro) have changed the treatment landscape, making meaningful weight loss achievable for men who have struggled with diet and exercise alone. This guide covers everything Singaporean men need to know about medical weight loss options.


Table of Contents

  1. What Is Medical Weight Loss?
  2. Understanding GLP-1 Medications
  3. Medications Compared: Semaglutide, Tirzepatide & More
  4. Who Qualifies for Medical Weight Loss?
  5. Online Weight Loss Treatment in Singapore
  6. Cost of Weight Loss Treatment in Singapore
  7. What to Expect: Results Timeline
  8. Side Effects and Safety
  9. Lifestyle Integration
  10. FAQ

What Is Medical Weight Loss? {#what-is-medical-wl}

Medical weight loss refers to the use of prescription medications, under medical supervision, to achieve and maintain weight loss. Unlike fad diets or over-the-counter supplements, medical weight loss is evidence-based, clinically supervised, and produces measurable results.

The field has been revolutionised by GLP-1 receptor agonists — medications originally developed for Type 2 diabetes that were found to produce significant weight loss as a beneficial side effect. Dedicated weight loss formulations (higher doses of the same active ingredients) have since been developed and approved.

Why Medication?

Obesity is a chronic medical condition driven by complex interactions between genetics, hormones, environment, and behaviour. The body has powerful hormonal systems that resist weight loss and promote weight regain — this is why dieting alone fails for the majority of people long-term.

GLP-1 medications work with these hormonal systems rather than against them, reducing hunger and increasing satiety at a physiological level. This is not about willpower — it's about biology.


Understanding GLP-1 Medications {#glp1}

GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone produced in the gut after eating. It plays several roles in metabolism and appetite regulation.

How GLP-1 Medications Work

GLP-1 receptor agonists mimic the natural GLP-1 hormone but with a much longer duration of action. They work through multiple mechanisms:

  • Appetite suppression — act on brain centres that control hunger and satiety, reducing appetite and food cravings2
  • Delayed gastric emptying — food stays in the stomach longer, increasing feelings of fullness
  • Improved insulin sensitivity — enhance the body's response to insulin, improving blood sugar control
  • Reduced glucagon secretion — lower the hormone that raises blood sugar

The net effect: you feel less hungry, get full sooner, and are less driven by food cravings — making it significantly easier to maintain a caloric deficit.

GLP-1 vs GLP-1/GIP Dual Agonists

Tirzepatide (Mounjaro) is a dual GLP-1/GIP receptor agonist — it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism appears to produce greater weight loss than GLP-1 agonists alone in head-to-head trials1.


Medications Compared: Semaglutide, Tirzepatide & More {#medications}

Several GLP-1 medications are available or becoming available in Singapore. Here's how they compare.

Comparison Table

Medication Brand Name Route Frequency Avg Weight Loss HSA Status
Semaglutide 2.4 mg Wegovy Injection Weekly ~15% body weight Registered
Semaglutide 1.0 mg Ozempic Injection Weekly ~10% body weight Registered (diabetes indication)
Semaglutide oral Rybelsus Oral tablet Daily ~8-10% body weight Registered
Tirzepatide Mounjaro Injection Weekly ~18-22% body weight Registered

Weight loss percentages from clinical trials (STEP, SURMOUNT programmes). Individual results vary.21

Semaglutide (Ozempic / Wegovy / Rybelsus)

Semaglutide is the most widely studied GLP-1 for weight management. The STEP clinical trial programme demonstrated:

  • STEP 1: 2.4 mg weekly semaglutide produced mean weight loss of 14.9% vs 2.4% with placebo over 68 weeks2
  • STEP 2: Significant weight loss in patients with Type 2 diabetes
  • Results sustained with continued treatment

Tirzepatide (Mounjaro)

Tirzepatide has shown the highest weight loss in clinical trials:

  • SURMOUNT-1: Mean weight loss of 20.9% with the highest dose (15 mg) over 72 weeks1
  • Dual GLP-1/GIP mechanism may explain the superior efficacy
  • Initially approved for diabetes; weight management indication following

Oral vs Injectable

Rybelsus (oral semaglutide) offers a needle-free option, though with somewhat lower efficacy than injectable semaglutide at maximum weight loss doses. It must be taken on an empty stomach with a small sip of water, and you must wait 30 minutes before eating.

Read more: Rybelsus vs Ozempic (SG-N-WL-01)


Who Qualifies for Medical Weight Loss? {#eligibility}

Medical weight loss treatment is appropriate for adults who meet specific clinical criteria, ensuring that medication is used where it provides meaningful health benefit.

General Eligibility Criteria

  • BMI ≥30 (obese) — qualifies for treatment
  • BMI ≥27 with weight-related comorbidities (diabetes, hypertension, dyslipidaemia, sleep apnoea) — qualifies for treatment
  • BMI thresholds may be lower for Asian populations — WHO recommends lower BMI cut-offs for Asians (overweight: ≥23; obese: ≥27.5), reflecting higher metabolic risk at lower BMIs

Singapore Context

Singapore uses Asian-adjusted BMI cut-offs:

Classification BMI (Asian)
Normal weight 18.5–22.9
Overweight 23.0–27.4
Obese ≥27.5

This means many Singaporean men who would be classified as "merely overweight" by global standards are actually at the obesity threshold by Asian criteria — and may qualify for medical weight loss treatment.

Who Should NOT Use GLP-1 Medications

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis (use with caution)
  • Pregnancy or planning pregnancy
  • Severe gastrointestinal disease

Online Weight Loss Treatment in Singapore {#online-treatment}

noah™ provides MOH-compliant online access to medical weight loss treatment, combining doctor oversight with convenient home delivery.

How noah™ Works

  1. Health assessment — complete an online questionnaire covering weight history, medical conditions, medications, and goals
  2. Doctor consultation — an SMC-registered doctor reviews your assessment and discusses treatment options
  3. Treatment plan — personalised medication, dosing, and lifestyle guidance
  4. Medication delivery — delivered discreetly to your door
  5. Ongoing monitoring — regular check-ins, weight tracking, dose adjustments

Why Online Works for Weight Loss

  • Regular monitoring — the subscription model ensures consistent medication access and doctor oversight
  • Privacy — many men prefer not to discuss weight in a clinic setting
  • Dose titration support — GLP-1 medications require gradual dose increases; noah™ guides you through this
  • Lifestyle coaching — dietary and exercise guidance alongside medication

Cost of Weight Loss Treatment in Singapore {#cost}

GLP-1 medications represent a significant investment. Understanding the cost landscape helps you plan appropriately.

Medication Costs (SGD)

Medication Monthly Cost (Approximate)
Ozempic (semaglutide 1.0 mg injectable) S$350–500
Wegovy (semaglutide 2.4 mg injectable) S$500–700
Rybelsus (oral semaglutide) S$300–450
Mounjaro (tirzepatide) S$400–600

Prices vary by provider and dose. noah™ pricing may differ. Updated April 2026.

Why Are These Medications Expensive?

GLP-1 medications are biologic or complex pharmaceutical products with significant R&D investment. Generic competition is limited (especially for injectables). As more products enter the market, prices are expected to decrease gradually.

Insurance and Subsidies

  • Most private insurance plans do not cover weight loss medications
  • MediSave does not cover weight loss treatment
  • If weight loss medication is prescribed as part of diabetes management, some costs may be claimable under CDMP
  • noah™ offers subscription plans to help manage costs

What to Expect: Results Timeline {#results}

GLP-1 medications work gradually. Understanding the typical timeline helps set realistic expectations and maintain motivation.

Typical Timeline

Week What to Expect
1–2 Reduced appetite; some may experience nausea
2–4 Early weight loss (1–2 kg); appetite notably reduced
4–8 Consistent weekly weight loss (0.5–1 kg/week)
8–16 Dose increases as tolerated; continued weight loss
16–24 Approaching half of expected total weight loss
24–52 Continued weight loss; approaching maximum effect
52+ Weight maintenance phase; continued medication recommended

Realistic Weight Loss Goals

Based on clinical trials:

  • Semaglutide 2.4 mg: Average 15% of body weight over 68 weeks2
  • Tirzepatide 15 mg: Average 21% of body weight over 72 weeks1

For an 85 kg man, this means: - Semaglutide: ~12.8 kg loss → 72.2 kg - Tirzepatide: ~17.9 kg loss → 67.1 kg

Individual results vary. Some men lose more, some less.


Side Effects and Safety {#side-effects}

GLP-1 medications have a well-characterised side effect profile. Most side effects are gastrointestinal and improve over time, but understanding them helps you prepare.

Common Side Effects

  • Nausea — the most common; usually worst during dose increases and improves over 2–4 weeks
  • Diarrhoea or constipation — either can occur; usually transient
  • Vomiting — less common than nausea; dose adjustment may help
  • Decreased appetite — this is actually the intended therapeutic effect

Managing Side Effects

  • Start low, go slow — gradual dose titration minimises GI side effects
  • Eat smaller meals — your capacity is reduced; don't force large portions
  • Stay hydrated — particularly important if experiencing nausea or diarrhoea
  • Avoid fatty or heavy foods — these are harder to tolerate initially
  • Report persistent symptoms — your noah™ doctor can adjust dosing or timing

Serious but Rare Side Effects

  • Pancreatitis — rare; seek immediate care for severe abdominal pain
  • Gallbladder issues — rapid weight loss can increase gallstone risk
  • Thyroid concerns — animal studies showed thyroid C-cell tumours; not confirmed in humans; contraindicated in those with MTC history

Read more: GLP-1 Side Effects Guide (SG-N-WL-04)


Lifestyle Integration {#lifestyle}

Medication alone produces significant results, but combining it with lifestyle changes maximises outcomes and supports long-term weight maintenance.

Diet

  • Prioritise protein — reduced appetite means fewer calories overall; ensure adequate protein (1.2–1.6 g/kg/day) to preserve lean muscle mass4
  • Eat whole foods — fruits, vegetables, whole grains, lean meats
  • Reduce processed foods — calorie-dense foods with low nutritional value
  • Don't skip meals — regular, smaller meals work better than feast-or-famine patterns

Exercise

  • Resistance training — especially important during weight loss to preserve muscle mass
  • Aerobic exercise — 150 minutes/week as per HPB guidelines
  • Stay active — general daily movement (walking, taking stairs) adds up

Monitoring

  • Weigh weekly — same time, same conditions (morning, after bathroom)
  • Track trends, not daily fluctuations — weight varies by 1–2 kg day to day
  • Progress photos — monthly photos capture changes that the scale doesn't

FAQ {#faq}

1. Is medical weight loss "cheating"?

No. Obesity is a chronic medical condition with hormonal, genetic, and environmental drivers. Using medication to treat it is no different from using medication to treat hypertension or diabetes. You wouldn't call insulin "cheating" for diabetics.

2. Will I regain weight if I stop medication?

Clinical data suggests that weight regain does occur after discontinuation in many patients3. This is consistent with obesity being a chronic condition requiring ongoing management. Your doctor will help you develop a long-term strategy.

3. Can I use these medications if I'm not obese but want to lose weight?

Medical weight loss is designed for individuals who meet clinical criteria (BMI ≥27.5 Asian cut-off, or ≥25 with comorbidities). Using these medications for cosmetic weight loss in healthy-weight individuals is not recommended and may not be prescribed.

4. Ozempic vs Wegovy — what's the difference?

Same active ingredient (semaglutide), same manufacturer (Novo Nordisk). Ozempic is approved for Type 2 diabetes (max 1.0 mg/week); Wegovy is approved for weight management (max 2.4 mg/week). The weight loss dose is higher.

5. Are GLP-1 medications safe long-term?

The longest clinical trial data (STEP extensions, SELECT trial) show maintained efficacy and safety over 2+ years. Semaglutide has also demonstrated cardiovascular benefits in the SELECT trial (reduced risk of major cardiovascular events)3. Long-term registry data continues to accumulate.

6. Can I drink alcohol while on GLP-1 medication?

Moderate alcohol is generally compatible, but be aware that: (a) alcohol is calorie-dense and may undermine weight loss goals; (b) GLP-1 medications may change your alcohol tolerance; (c) heavy drinking increases pancreatitis risk.

7. Will my GP prescribe these medications?

Some GPs are comfortable prescribing GLP-1 medications; others may refer to an endocrinologist. noah™ provides convenient online access with doctors experienced in medical weight loss management.

8. How does noah™ handle dose titration?

GLP-1 medications are started at low doses and gradually increased over weeks to months. noah™ provides a structured titration schedule, regular check-ins, and dose adjustments based on your response and tolerability.

9. Can I use GLP-1 medications with other weight loss supplements?

Discuss all supplements with your doctor. Most over-the-counter weight loss supplements have no proven efficacy and may interact with prescription medications. GLP-1 agonists are effective on their own — additional supplements are generally unnecessary.

10. What happens during medication shortages?

GLP-1 medication supply has been constrained globally. noah™ monitors supply proactively and communicates alternatives if your medication is temporarily unavailable. Options may include switching between brands/formulations under medical guidance.


References


This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only in Singapore. Always consult a licensed doctor before starting any treatment. noah™ consultations are conducted by SMC-registered doctors in accordance with MOH telemedicine guidelines.

© 2026 noah™ — A brand of Ordinary Folk Pte. Ltd.


  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. PMID: 35658024 

  2. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185 

  3. Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA. 2021;325(14):1414-1425. PMID: 29617641 

  4. Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes. JAMA. 2015;314(7):687-699. PMID: 26132939 

Find out what your BMI indicates

Your BMI indicates that you may be
Slider
BMI provides an estimate of weight classification. For a thorough analysis of your weight and medical options, arrange a teleconsult with a Noah doctor.

*Medical treatment may not be appropriate for you even if you have a high BMI
Your estimated weight loss in 1 year*
-
00
kg
-9%
90
kg
78
kg
99
81
63
Weight loss progress graph on transparent background showing treatment results
*In a 56-week trial with 3,731 non-diabetic overweight (BMI ≥27) or obese (BMI ≥30) participants, those who finished (1,812 patients) lost an average of 9.2% body weight with Saxenda, alongside diet and exercise.
No items found.
Written by our Editorial Team
Last updated
7/4/2026
disclaimer

Articles featured on Noah are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider.